Picture of Tempus AI logo

TEM — Tempus AI News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge CapHigh Flyer

Tempus AI Q3 revenue slightly beats estimates; raises guidance

Tempus AI Q3 revenue slightly beats estimates; raises guidance


Overview

  • AI-driven precision medicine firm's Q3 revenue rose 23%, slightly beating analyst expectations

  • Adjusted EPS for Q3 turned positive and beat analyst expectations

  • Company raised full-year 2026 revenue guidance and announced new collaborations with Merck, Moderna, and BMS


Outlook

  • Tempus raises full-year 2026 revenue guidance to $1.60-$1.605 bln

  • Company maintains 2026 adjusted EBITDA outlook at ~$65 mln


Result Drivers

  • ONCOLOGY VOLUME - Co said 32% growth in oncology test volumes drove diagnostics revenue

  • DATA & APPS MOMENTUM - Co said Data & Applications revenue grew 33%, with Insights up 29%

  • STRATEGIC COLLABORATIONS - Co cited new deals with Merck, Moderna and BMS as supporting growth


Company press release: ID:nBw7Sgzc3a


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Beat*

$411.54 mln

$409.35 mln (20 Analysts)

Q3 Adjusted EPS

Beat

$0.07

-$0.08 (16 Analysts)

Q3 Net Loss

$14.85 mln

Q3 Adjusted EBITDA

Beat

$25.57 mln

$18.75 mln (14 Analysts)

Q3 Income from Operations

-$56.86 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 11 "hold" and 1 "sell" or "strong sell"

  • The average consensus recommendation for the biotechnology & medical research peer group is "buy"

  • Wall Street's median 12-month price target for Tempus AI, Inc. is $75.00, about 3.8% above its October 30 closing price of $72.22


Reuters Recommended Reads

  • Oct 30 - Kuaishou's Kling AI unit completes a near $3 billion funding round


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Tempus AI

See all news